Search results for " Parasitic diseases"

showing 10 items of 182 documents

Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania.

2011

Background HIV-associated anemia is common and associated with poor prognosis. However, its response to antiretroviral treatment (ART) in rural Africa is poorly understood. Methods HIV-infected adults (≥15 years) who enrolled in HIV care at Haydom Lutheran Hospital in northern Tanzania were included in the study. The effect of ART (zidovudine/stavudine + lamivudine + efavirenz/nevirapine) on HIV-associated anemia was studied in a subset of patients who were anemic at the time they started ART and had a follow-up hemoglobin measurement 12 months later. Pregnant women were excluded from the study, as were women who had given birth within the past 6 weeks. Anemia was defined as hemoglobin <12 …

AdultMalemedicine.medical_specialtyNevirapineAnemiaPopulationVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Communicable diseases: 776HIV InfectionsTanzanialcsh:Infectious and parasitic diseasesHemoglobinsVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Infeksjonsmedisin: 776Risk FactorsInternal medicinemedicineHumanslcsh:RC109-216educationeducation.field_of_studyChi-Square Distributionbusiness.industryMicrocytosisStavudineLamivudineAnemiamedicine.diseaseSurgeryInfectious DiseasesLogistic ModelsAnti-Retroviral AgentsHypochromiaMultivariate AnalysisFemaleHemoglobinbusinessmedicine.drugResearch ArticleBMC infectious diseases
researchProduct

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania

2009

Background Virological response to antiretroviral treatment (ART) in rural Africa is poorly described. We examined virological efficacy and emergence of drug resistance in adults receiving first-line ART for up to 4 years in rural Tanzania. Methods Haydom Lutheran Hospital has provided ART to HIV-infected patients since October 2003. A combination of stavudine or zidovudine with lamivudine and either nevirapine or efavirenz is the standard first-line regimen. Nested in a longitudinal cohort study of patients consecutively starting ART, we carried out a cross-sectional virological efficacy survey between November 2007 and June 2008. HIV viral load was measured in all adults who had completed…

AdultMalemedicine.medical_specialtyNevirapineEfavirenzTime FactorsAnti-HIV AgentsHIV InfectionsVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Communicable diseases: 776Drug resistanceTanzanialcsh:Infectious and parasitic diseasesCohort StudiesZidovudinechemistry.chemical_compoundInternal medicineDrug Resistance ViralmedicineHumanslcsh:RC109-216Viremiabusiness.industryStavudineLamivudineResistance mutationVirologyInfectious DiseasesCross-Sectional StudieschemistryHIV-1FemalebusinessViral loadmedicine.drugResearch Article
researchProduct

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response

2009

Abstract Background Interferon-gamma (IFN-γ) release assays (IGRAs) were designed to detect latent tuberculosis infection (LTBI). However, discrepancies were found between the tuberculin skin test (TST) and IGRAs results that cannot be attributed to prior Bacille Calmètte Guerin vaccinations. The aim of this study was to evaluate tools for improving LTBI diagnosis by analyzing the IFN-γ response to RD1 proteins in prolonged (long-term response) whole blood tests in those subjects resulting negative to assays such as QuantiFERON-TB Gold In tube (QFT-IT). Methods The study population included 106 healthy TST+ individuals with suspected LTBI (recent contact of smear-positive TB and homeless) c…

AdultMalemedicine.medical_specialtyTuberculosisTuberculinlcsh:Infectious and parasitic diseasesMycobacterium tuberculosisInterferon-gammaYoung AdultMedical microbiologyAntigenLatent TuberculosismedicineHumanslcsh:RC109-216tuberculosis latent infection IGRA testAntigens BacterialLatent tuberculosisbiologyTuberculin Testbusiness.industryMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationbacterial infections and mycosesVaccinationLong term responseInfectious DiseasesImmunologyFemaleReagent Kits DiagnosticbusinessResearch ArticleBMC Infectious Diseases
researchProduct

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy

2022

Abstract Background It has been estimated that the incidence of chronic hepatitis C virus (HCV) will not decline over the next 10 years despite the improved efficacy of antiviral therapy because most patients remain undiagnosed and/or untreated. This study aimed to investigate the opinion of relevant target populations on the practicability, effectiveness and best modalities of the test-and-treat approach in the fight against HCV in Italy. Methods A survey was delivered to patients with HCV from the general population, patients from drug addiction services, hospital physicians and healthcare providers for drug addiction services. Results For both hospital clinicians and SerD HCPs, tolerabil…

Antiviral AgentHealthcare serviceconjoint analysis; HCV; healthcare services; meet–test–treat; point of care; preferences; antiviral agents; hospitals; humans; incidence; hepatitis c; hepatitis c chronic; substance-related disordersResearchMeet–Test–TreatInfectious and parasitic diseasesRC109-216Hepatitis C ChronicPreferencePoint of carechronicsubstance-related disordersConjoint analysiHospitalInfectious DiseasesPreferencesantiviral agentsHCVincidencehepatitis chospitalshumansConjoint analysisHealthcare servicesHumanBMC Infectious Diseases
researchProduct

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.

2022

Abstract Background Although an increase in hepatitis C virus (HCV) prevalence from Northern to Southern Italy has been reported, the burden of asymptomatic individuals in different Italian regions is currently unknown. Methods A probabilistic approach, including a Markov chain for liver disease progression, was applied to estimate current HCV viraemic burden. The model defined prevalence by geographic area using an estimated annual historical HCV incidence by age, treatment rate, and migration rate from the Italian National database. Viraemic infection by age group was estimated for each region by main HCV transmission routes of individuals for stage F0–F3 (i.e. patients without liver cirr…

Antiviral AgentLiver CirrhosisHepaciviruLiver CirrhosiResearchMarkov chainUndiagnosedInfectious and parasitic diseasesRC109-216HepacivirusHepatitis C ChronicModels TheoreticalAntiviral AgentsHepatitis CInfectious DiseasesHCVPrevalenceHumansHepatitis C infectionHumanBMC infectious diseases
researchProduct

Candida glabrata meningitis and endocarditis: a late severe complication of candidemia

2014

SummaryWe report an unusual case of Candida glabrata meningitis and endocarditis in a young Caucasian woman with a prosthetic aortic valve and suffering from a dissecting thoraco-abdominal aortic aneurysm. C. glabrata was isolated from culture of the cerebrospinal fluid. Candida infection of the central nervous system is an uncommon manifestation of disseminated infection due to Candida species. Our case report also highlights the intrinsic resistance of C. glabrata to azoles.

Aortic valveMicrobiology (medical)AdultSettore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialtySettore MED/17 - Malattie InfettiveIntrinsic resistanceCandida glabrataBiologylcsh:Infectious and parasitic diseasesAortic aneurysmCerebrospinal fluidmedicineEndocarditisHumanslcsh:RC109-216MeningitisSevere complicationCandida glabrataEndocarditisCandidemiaGeneral Medicinemedicine.diseasebiology.organism_classificationbacterial infections and mycosesSurgeryMeningitis Fungalmedicine.anatomical_structureInfectious Diseasescardiovascular systemFemaleCandida glabrata Candidemia Meningitis EndocarditisMeningitisInternational Journal of Infectious Diseases
researchProduct

Enterococcal meningitis caused by Enterococcus casseliflavus. First case report

2005

Abstract Background Enterococcal meningitis is an uncommon disease usually caused by Enterococcus faecalis and Enterococcus faecium and is associated with a high mortality rate. Enterococcus casseliflavus has been implicated in a wide variety of infections in humans, but never in meningitis. Case presentation A 77-year-old Italian female presented for evaluation of fever, stupor, diarrhea and vomiting of 3 days duration. There was no history of head injury nor of previous surgical procedures. She had been suffering from rheumatoid arthritis for 30 years, for which she was being treated with steroids and methotrexate. On admission, she was febrile, alert but not oriented to time and place. H…

BACTEREMIACase ReportMicrobial Sensitivity TestsVANCOMYCIN-RESISTANT ENTEROCOCCI; CLINICAL-FEATURES; BACTEREMIA; GALLINARUM; MOTILE ENTEROCOCCUS; OUTCOMESMeropenemEnterococcus faecalisVANCOMYCIN-RESISTANT ENTEROCOCCIlcsh:Infectious and parasitic diseaseslaw.inventionMicrobiologyMeningitis BacteriallawAmpicillinmedicineEnterococcus casseliflavusHumanslcsh:RC109-216Gram-Positive Bacterial InfectionsAgedCerebrospinal FluidOUTCOMESSigmoid Diseasesbiologybusiness.industryCLINICAL-FEATURESMeropenembiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseAnti-Bacterial AgentsMOTILE ENTEROCOCCUSInfectious DiseasesGram stainingEnterococcusSulbactamGALLINARUMAmpicillinFemaleThienamycinsbusinessMeningitisEnterococcusmedicine.drugEnterococcus faeciumBMC Infectious Diseases
researchProduct

A divergent Anaplasma phagocytophilum variant in an Ixodes tick from a migratory bird; Mediterranean basin

2020

Anaplasma phagocytophilum (AP) has vast geographical and host ranges and causes disease in humans and domesticated animals. We investigated the role of northward migratory birds in the dispersal of tick-borne AP in the African-Western Palearctic. Ticks were collected from northward migratory birds trapped during spring migration of 2010 at two localities in the central Mediterranean Sea. AP DNA was detected by PCR (gltA and 16S rRNA) and variant determination was performed using ankA sequences. In total, 358 ticks were collected. One of 19 ticks determined as Ixodes was confirmed positive for AP DNA. The tick was collected from a woodchat shrike (Lanius senator senator) trapped in Greece, a…

Bird migration040301 veterinary sciencesEpidemiologyHyalomma marginatum030231 tropical medicineBird migrationZoologyHyalomma marginatum s.l.Infectious and parasitic diseasesRC109-216Environmental Science (miscellaneous)TickMicrobiology0403 veterinary science03 medical and health sciences0302 clinical medicineankAparasitic diseasesAfrican-Western Palearctic region16s rRNALanius senatorbiology16s rRNA; African-Western Palearctic region; Anaplasma phagocytophilum; Bird migration; Hyalomma marginatum s.l.; Ixodes; ankAIxodesanaplasma phagocytophilumixodes04 agricultural and veterinary sciencesbiology.organism_classificationbacterial infections and mycosesAnaplasma phagocytophilumMikrobiologiankaEnzooticIxodesafrican-western palearctic regionHyalommabird migrationhyalomma marginatum s.l.16s rrnaAnaplasma phagocytophilum
researchProduct

Insights into the relationships of Palearctic and Nearctic lymnaeids (Mollusca : Gastropoda) by rDNA ITS-2 sequencing and phylogeny of stagnicoline i…

2003

Fascioliasis by Fasciola hepatica is the vector-borne disease presenting the widest latitudinal, longitudinal and altitudinal distribution known. F. hepatica shows a great adaptation power to new environmental conditions which is the consequence of its own capacities together with the adaptation and colonization abilities of its specific vector hosts, freshwater snails of the family Lymnaeidae. Several lymnaeid species only considered as secondary contributors to the liver fluke transmission have, however, played a very important role in the geographic expansion of this disease. Many of them belong to the so-called "stagnicoline" type group. Stagnicolines have, therefore, a very important a…

CanadaVeterinary (miscellaneous)SnailsZoologyDisease VectorsDNA RibosomalRibotypingrDNA ITS-2 sequenceslymnaea occultalcsh:Infectious and parasitic diseasesHolarcticSpecies SpecificityPhylogeneticsHepaticaSequence Homology Nucleic AcidOmphiscola glabraAnimalslcsh:RC109-216PhylogenyLymnaeaGalba truncatulabiologyPhylogenetic treeArctic RegionsIntermediate hostHolarctic stagnicolinesFasciola hepaticabiology.organism_classificationEuropeInfectious DiseasesInsect ScienceAnimal Science and ZoologyParasitologyTaxonomy (biology)L. palustris turriculaParasite
researchProduct

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

2010

Abstract Background To clarify the immunological alterations leading to classical Kaposi sarcoma (cKS) among people infected with KS-associated herpesvirus (KSHV). Methods In a population-based study of 119 cKS cases, 105 KSHV-seropositive controls, and 155 KSHV-seronegative controls, we quantified plasma soluble cluster of differentiation (sCD) levels and antibodies against Epstein-Barr virus nuclear antigen-1 (anti-EBNA-1) and viral capsid antigen (anti-VCA). Differences between groups in prevalence of low-tertile anti-EBNA-1 and high-tertile anti-VCA were compared by logistic regression. Continuous levels between groups and by presence of cKS co-factors among controls were compared by li…

Cancer ResearchEpidemiologyPopulationmedicine.disease_causeSettore MED/42 - Igiene Generale E Applicatalcsh:RC254-282Viruslcsh:Infectious and parasitic diseasesDiabetes mellitusmedicinelcsh:RC109-216educationeducation.field_of_studyEpstein-Barr virus antibodiebiologyCluster of differentiationbusiness.industryKaposi sarcomasCD26 sCD23 and sCD30lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseEpstein–Barr virusInfectious DiseasesOncologyImmunologyKaposi sarcoma; Epstein-Barr virus antibodies; sCD26 sCD23 and sCD30biology.proteinSarcomaCortisoneAntibodybusinessmedicine.drugResearch ArticleInfectious Agents and Cancer
researchProduct